*These authors contributed equally to this work.
Version of Record online: 10 JAN 2011
Copyright © 2010 American Association for the Study of Liver Diseases
Volume 53, Issue 2, pages 596–603, February 2011
How to Cite
Berres, M.-L., Trautwein, C., Schmeding, M., Eurich, D., Tacke, F., Bahra, M., Neuhaus, P., Neumann, U. P. and Wasmuth, H. E. (2011), Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection. Hepatology, 53: 596–603. doi: 10.1002/hep.24098
Potential conflict of interest: Nothing to report.
Parts of the analyses were supported by grants from the Deutsche Forschungsgemeinschaft (SFB-TRR 57 P08) to Hermann E. Wasmuth.
- Issue online: 27 JAN 2011
- Version of Record online: 10 JAN 2011
- Accepted manuscript online: 6 DEC 2010 12:38PM EST
- Manuscript Accepted: 14 OCT 2010
- Manuscript Received: 5 AUG 2010
Additional Supporting Information may be found in the online version of this article.
|Hep_24098_sm_suppfig1.tif||439K||Supporting Figure 1.|
|Hep_24098_sm_supptables.doc||29K||Supporting Table 1 Univariate analysis of parameters associated with fibrosis stage in protocol biopsy at year one. Table 2 Correlation of standard laboratory parameters with CXCL10 serum levels.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.